Treatment of peritoneal carcinoma of colorectal origin;Traitement de la carcinose peritoneale d'origine colorectale

Journal de Chirurgie

Volumn 134, Issue 5-6, 1997, Pages 233-236

  Dube P ^a   Lasser, Ph ^a   Elias D ^b  

^a Chirurgie Carcinologique ^*

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORECTAL CANCER; HUMAN; PATHOPHYSIOLOGY; PERITONEUM CANCER; PERITONEUM METASTASIS; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR BLOOD FLOW; ADJUVANT CHEMOTHERAPY; CARCINOMA; COLON TUMOR; FOLLOW UP; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; METASTASIS; PATHOLOGY; PERITONEUM TUMOR; PEROPERATIVE CARE; RECTUM TUMOR; REVIEW;

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; INTRAOPERATIVE CARE; PERITONEAL NEOPLASMS; RECTAL NEOPLASMS;

EID: 0031267220     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995 ; 221(2) : 124-32.
2. Bleeker WA, de Vries EG, Dolosma WV, Ground J, Verscheren RC. Long-term disease-free survival after isolated peritoneal metastasis from colonic cancer. Eur J Surg Oncol 1994 ; 20(6) : 698-700.
3. Spratt J, Edwards M, Kubota T, Lindberg R, Tseng MT. Peritoneal carcinomatosis: Anatomy, physiology, diagnosis and management. Curr Probl Cancer 1986 : 10 ; 553-84.
4. Jacquet P, Vidal-Jove J, Zhu B, Sugarbaker PH. Peritoneal carcinomatosis from gastrointestinal malignancy: Natural history and new prospects for management. Acta Chir Belg 1994 ; 94(4) : 191-7.
5. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghaussen SE, Dalton RR, Steves MA, Sugarbaker PH. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996 ; 77(12) ; 2622-9.
6. Gwin J, Hoffman J, Eisengerg B. Surgical management of non hapatic intra-abdominal recurrence of carcinoma of the colon. Dis Col Rectum 1993 ; 36(6) : 540-4.
7. Jacquet P, Elias D, Sugarbaker PH. L'implantation tumorale dans les sites de cicatrisation après chirurgie des cancers digestifs: Mise au point. (Communication personelle).
8. Zeng Z, Cohen A, Haidu S, et al. Serosal cyrologic study to determine free mesothelial penetration of intra-peritoneal colon cancer. Cancer 1992 ; 70 : 737-42.
9. Zirngilb H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Col Rectum 1990 ; 33 : 610-4.
10. Turnbull A, Guerra J, Starnes H. Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic or biliary origin. J Clin Oncol 1989 ; 7 : 383-6.
11. Salsbury AJ, McKinna SA, Griffiths JD, Nauton-Morgan C. Circulating cancer cells during excision of the rectum and colon with high ligation of the inferior mesenteric vein. Surg Gynecol Obst 1965 ; 120 : 1266-70.
12. Hansen E, Wolff N, Knuechel R, Rushoff J, Hofsaedter F, Taeger K, Tumor cells in blood shed from the surgical field. Arch Surg 1995 ; 130 : 387-93.
13. Weiss L. Metastasis inefficiency: Causes and consequences. Cancer Rev 1986 ; 3 : 1-24.
14. Guillou PJ. Adjuvant biological response modifiers after major surgery or trauma. Br J Surg 1995 ; 82 : 721-3.
15. Little D, Regan M, Keane RM, Bouchier-Hayes D. Perioperative immune modulation. Surgery 1993 ; 114 : 91-7.
16. Zoetmulder F. Agressive cytoreductive surgery combined with hyperthermic intraperitoneal carcinosis of colorectal origin. Deutch Cancer Society. (Communication personnelle).
17. Menzies D. Peritoneal adhesions: Incidence, causes and prevention. Ann Surg 1992 ; 24(1) : 27-45.
18. Sugarbaker PH, Cunliffe WJ, Belliveau J et al. Rational for integrating early post-operative intra-peritoneal chemotherapy in the surgical treatment of gastrointestinal cancers. Semin Oncol 1989 ; 16 : 83-97.
19. Kemeny et al. Current approches to metastatic colorectal cancer. Semin Oncol 1994 ; 21 : 67-75.
20. Moertel G et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. New Engl J Med 1990 ; 322(6) : 352-9.
21. Laurie et al. Surgical adjuvant therapy of large bowel carcinoma: An evaluation of Levamisole and the combinaison of Levamisole and Fluorouracil. J Clin Onc 1989 ; 7(10) : 1447-56.
22. Mayer RJ. Systemique therapy for colorectal cancer: an overview. Sem Oncol 1991 ; 18 (5 suppl 7) : 62-6.
23. Mizoguchi T, Yamanda K, Furukawa T, et al. Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 1990 ; 82 : 1679-83.
24. Grogon L, Sotos GA, Allegra CJ. Leucovorin modulation of fluorouracil. Oncology 1993 ; 7(8) : 63-72.
25. Elias D. La chirurgie de cytoréduction tumorale : mythe ou réalité. J Chir 1992 ; 129 : 479-83.
26. Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Sem Oncol 1985 ; 12 (suppl 4) : 23-8.
27. Sugarbaker PH, Gianola FS, Speyer JC, Wesley R et al. Prospective, randomized trial of intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Surg 1985 ; 98 : 414-22.
28. Sautener T, Hofbauer F, Depish F, Schissel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long term survival after surgery for advanced gastric cancer. J Clin Oncol 1994 ; 12 : 970-4.
29. Brenner DE. Intraperitoneal chemotherapy: a review. J Clin Oncol 1986, 4: 1135-47.
30. Nordlinger B, Bouteloup PY, Favre JP, Jaek D, Pellisier JP, Grandjean JP, et al. Early postoperative intraperitoneal chemotherapy (IPC) is feasible and well tolerated in colon cancer. A prospective randomized study. J Cancer Res Clin Oncol 1990; 116: A686.
31. Hillan K, Nordlinger B, Ballet F, Puts JP, Infante R. The healing of colonic anastomosis after early intraperitoneal chemotherapy: An experimental study in rats. J Surg Res 1988 ; 44 : 166-71.
32. de Waard JW, Whobbes T, Hendriks T. Early postoperative 5-fluorouracil does not affect the healing of the experimental intestinal anastomosis. Int J Colorect Dis 1993 ; 8 : 175-8.
33. Sugarbaker PH, Cuniffe W, Belliveau JF, De Bruine E, Graves T. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1988 ; 1 : 66-79.
34. Elias D. La chimiothérapie intra-péritonéale immédiate après chirurgie de cytoréduction dans les carcinoses péritonéales : Pourquoi? Pour qui? Ann Chir 1995 ; 49(7) : 567-72.
35. Sugarbaker PH. Peritonectomy procedure. Ann Surg 1995 ; 221 ; 29-42.
36. Elias D, Bonvallot S, Gachot B, Blot F, Sabourin JC, Ducreux M, Rougier P, Lasser P. Carcinoses péritonéales traitées par exérèse complète et chimiothérapie intra-péritonéale postopératoire immédiate (CIPPI). Journées francophone de pathologie digestives (Strasbourg 1997). A170.
37. Sugarbaker PH, Graves T, Debruijn EA et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: Pharmaclolgical studies. Cancer Res 1990 ; 50 : 5790-4.
38. Elias D, Detroz B, Debane B, Damia E et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: Reliable and unreliable concepts. Hepato-gastroenterol 1994 ; 41 : 207-13.
39. Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B et al. Regional chemotherapy (with mitomycin C) and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 1994 ; 41 : 124-9.
40. Yamaguchi A, Tsukioka Y, Fushida S, Kurosaka Y, Kanno M, Yonemura Y et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers. Dis Col Rectum 1992 ; 35 : 964-8.
41. Stewart FK. Clinical hyperthermia and chemotherapy. Radiol Clin N America 1989 ; 27(3) : 621-7.
42. Leunig M, Goetz AE, Dellian M et at. Interstitial fluid pressure in solid tumors following hyperthermia: Possible correlation with therapeutic response. Can Res 1992 ; 52 : 487-90.
43. Wallner K, Li G. Effect of drug exposure, duration and sequencing on hyperthermic potentiation of MMC and CPPD. Cancer Res 1987 ; 47 : 493-5.
44. Wallner KE, Branda M, Li GC. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant chinese hamster ovary cells. Cancer Res 1987 ; 47 : 1308-12.
45. Elias D, Damia E, Puizillout JM, Billard V et al. Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis. (Soumis).
46. Brodsky JT, Cohen AM. Peritoneal seeding following curative resection of colonic carcinoma: Implication for adjuvant therapy. Dis Col Rectum 1991 ; 34 : 723-7.
47. Sugarbaker PH, Schellinex MET, Chang D, Koslowe P et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996 ; 20 : 585-92.
48. Sugarbaker PH, Jablonski KA. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intra-peritoneal chemotherapy. Dis Col Rectum 1993 ; 36 : 323-9.
49. Roasi. Akerman's Surgical Pathology. Seventh Edition. 1989
50. Sugarbaker PH. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995 ; 19(2) : 235-40.